DOWLING & YAHNKE LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$2,000
-75.0%
12,0000.0%0.00%
-100.0%
Q2 2018$8,000
-11.1%
12,0000.0%0.00%0.0%
Q1 2018$9,000
-25.0%
12,000
+4.3%
0.00%0.0%
Q4 2017$12,000
-14.3%
11,5000.0%0.00%0.0%
Q3 2017$14,000
+27.3%
11,5000.0%0.00%0.0%
Q2 2017$11,000
-42.1%
11,5000.0%0.00%
-50.0%
Q1 2017$19,00011,5000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Abingworth LLP 327,350$943,0000.99%
DAFNA Capital Management LLC 421,500$1,218,0000.96%
Rhenman & Partners Asset Management AB 350,000$1,012,0000.18%
BOURGEON CAPITAL MANAGEMENT LLC 70,704$204,0000.13%
Piermont Capital Management Inc. 151,924$439,0000.11%
Virtus ETF Advisers LLC 46,269$134,0000.10%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 389,144$1,124,0000.08%
GLOBEFLEX CAPITAL L P 80,637$233,0000.06%
South Dakota Investment Council 900,000$2,601,0000.06%
FOX RUN MANAGEMENT, L.L.C. 33,100$96,0000.05%
View complete list of REGULUS THERAPEUTICS INC shareholders